BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29168930)

  • 1. Cyclodextrin encapsulation of daidzein and genistein by grinding: implication on the glycosaminoglycan accumulation in mucopolysaccharidosis type II and III fibroblasts.
    Fumić B; Jablan J; Cinčić D; Zovko Končić M; Jug M
    J Microencapsul; 2018 Jan; 35(1):1-12. PubMed ID: 29168930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids.
    Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Smolińska E; Mozolewski P; Malinowska M; Rychłowski M; Banecki B; Węgrzyn G; Gabig-Cimińska M
    Sci Rep; 2015 Mar; 5():9378. PubMed ID: 25797591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.
    Kingma SD; Wagemans T; IJlst L; Wijburg FA; van Vlies N
    J Inherit Metab Dis; 2014 Sep; 37(5):813-21. PubMed ID: 24699889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
    Daruházi AE; Kiss T; Vecsernyés M; Szente L; Szőke E; Lemberkovics E
    J Pharm Biomed Anal; 2013 Oct; 84():112-6. PubMed ID: 23810850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction.
    Yatsu FK; Koester LS; Lula I; Passos JJ; Sinisterra R; Bassani VL
    Carbohydr Polym; 2013 Oct; 98(1):726-35. PubMed ID: 23987405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle is disturbed in mucopolysaccharidosis type II fibroblasts, and can be improved by genistein.
    Moskot M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Węsierska M; Bocheńska K; Węgrzyn G
    Gene; 2016 Jul; 585(1):100-103. PubMed ID: 27016302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced delivery of daidzein into fibroblasts and neuronal cells with cationic derivatives of gamma-cyclodextrin for the control of cellular glycosaminoglycans.
    Kamiński K; Kujdowicz M; Kajta M; Nowakowska M; Szczubiałka K
    Eur J Pharm Biopharm; 2015 Apr; 91():111-9. PubMed ID: 25681746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
    Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
    Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II.
    Friso A; Tomanin R; Salvalaio M; Scarpa M
    Br J Pharmacol; 2010 Mar; 159(5):1082-91. PubMed ID: 20136838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine Fibroblasts and Primary Hepatocytes as Tools When Studying the Efficacy of Potential Therapies for Mucopolysaccharidosis Type I.
    Węsierska M; Nowicka W; Kloska A; Jakóbkiewicz-Banecka J; Malinowska M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
    Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
    Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose genistein aglycone therapy is safe in patients with mucopolysaccharidoses involving the central nervous system.
    Kim KH; Dodsworth C; Paras A; Burton BK
    Mol Genet Metab; 2013 Aug; 109(4):382-5. PubMed ID: 23845234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of iduronic acid biosynthesis by ebselen reduces glycosaminoglycan accumulation in mucopolysaccharidosis type I fibroblasts.
    Maccarana M; Tykesson E; Pera EM; Gouignard N; Fang J; Malmström A; Ghiselli G; Li JP
    Glycobiology; 2021 Nov; 31(10):1319-1329. PubMed ID: 34192316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones.
    Arfi A; Richard M; Gandolphe C; Scherman D
    J Inherit Metab Dis; 2010 Feb; 33(1):61-7. PubMed ID: 20084460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of cyclodextrins in the formulation of genistein part 1. Preparation and physicochemical properties of genistein complexes with native cyclodextrins.
    Daruházi AE; Szente L; Balogh B; Mátyus P; Béni S; Takács M; Gergely A; Horváth P; Szoke E; Lemberkovics E
    J Pharm Biomed Anal; 2008 Nov; 48(3):636-40. PubMed ID: 18757150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model.
    Malinowska M; Nowicka W; Kloska A; Węgrzyn G; Jakóbkiewicz-Banecka J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT).
    Marucha J; Tylki-Szymańska A; Jakóbkiewicz-Banecka J; Piotrowska E; Kloska A; Czartoryska B; Węgrzyn G
    Am J Med Genet A; 2011 Sep; 155A(9):2257-62. PubMed ID: 21834048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis.
    Stancanelli R; Mazzaglia A; Tommasini S; Calabrò ML; Villari V; Guardo M; Ficarra P; Ficarra R
    J Pharm Biomed Anal; 2007 Aug; 44(4):980-4. PubMed ID: 17482414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Hydroxypropyl-β-Cyclodextrin-Based Extract of Medicago sativa in the Treatment of Mucopolysaccharidoses.
    Fumić B; Končić MZ; Jug M
    Planta Med; 2017 Jan; 83(1-02):40-50. PubMed ID: 27220073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Original research paper. A superior preparation method for daidzein-hydroxypropyl-β-cyclodextrin complexes with improved solubility and dissolution: Supercritical fluid process.
    Pan H; Wang HB; Yu YB; Cheng BC; Wang XY; Li Y
    Acta Pharm; 2017 Mar; 67(1):85-97. PubMed ID: 28231046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.